APL-MONTELUKAST TABS montelukast (as sodium) 5mg chewable tablet blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

montelukast sodium, Quantity: 5.19 mg

Disponible depuis:

Arrotex Pharmaceuticals Pty Ltd

DCI (Dénomination commune internationale):

montelukast sodium

forme pharmaceutique:

Tablet, chewable

Composition:

Excipient Ingredients: mannitol; microcrystalline cellulose; hyprolose; croscarmellose sodium; iron oxide red; aspartame; magnesium stearate; Flavour

Mode d'administration:

Oral

Unités en paquet:

28, 14

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Prophylaxis and treatment of chronic asthma in adults and children 2 years of age and older. Symptomatic treatment of seasonal allergic rhinitis.

Descriptif du produit:

Visual Identification: Pink coloured, mottled, round, biconvex, uncoated tablets debossed with X on one side and 53 on other side; Container Type: Blister Pack; Container Material: Other composite material; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2013-01-07